HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02696 HENLIUS

Closed 10-23 16:08:09

51.150

+1.730

+3.50%

High51.350	Low48.000	Vol643.43K
Open49.900	D1 Closing49.420	Amplitude6.78%
Mkt Cap27.88B	Tradable Cap17.80B	Total Shares545.00M
T/O31.98M	T/O Rate0.18%	Tradable Shares348.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"HENLIUS","latestPrice":51.15,"timestamp":1792742889003,"preClose":49.42,"halted":0,"volume":643428,"delay":0,"changeRate":0.035006070416835226,"floatShares":348000000,"shares":545000000,"eps":1.7753093471273382,"marketStatus":"Closed","change":1.73,"latestTime":"10-23 16:08:09","open":49.9,"high":51.35,"low":48,"amount":31980594,"amplitude":0.067786,"askPrice":51.15,"askSize":4700,"bidPrice":51,"bidSize":2700,"shortable":3,"etf":0,"ttmEps":1.857463465375113,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":49.42,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":0.637359,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02696/tweets","defaultTab":"tweets","newsList":[{"id":"1125447946","title":"Hetronifly's ASTRIDE US Bridging Study to Be Presented Orally at ESMO 2026, Adding Fresh Evidence for the World's First Anti-PD-1 Antibody in First-Line Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1125447946","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125447946?lang=en_us&edition=fundamental","pubTime":"2026-10-19 20:30","pubTimestamp":1792413018,"startTime":"0","endTime":"0","summary":"According to a report, on October 19, 2026 local time, the European Society for Medical Oncology (ESMO) Annual Congress released research abstracts, and a total of 10 studies on the core product...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","02696","BK1161","HK0000165453.HKD","HK0000306685.HKD","HK0000306701.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171512864","title":"CITIC Securities Keeps \"Buy\" Rating on HENLIUS with Target Price of HK$122","url":"https://stock-news.laohu8.com/highlight/detail?id=1171512864","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171512864?lang=en_us&edition=fundamental","pubTime":"2026-10-18 19:31","pubTimestamp":1792323078,"startTime":"0","endTime":"0","summary":"On October 20-22 by the Huangpu River in Shanghai, the 2026 Sustainable Global Leaders Conference will return once again. Nobel Prize and Turing Award winners will speak on-site about the future and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","HK0000320223.HKD","EWH","02696","BK1161","HK0000320264.USD","HK0000306701.USD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131405792","title":"CITIC Securities Keeps Buy Rating on HENLIUS (02696) with HK$122 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1131405792","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131405792?lang=en_us&edition=fundamental","pubTime":"2026-10-15 17:46","pubTimestamp":1792057576,"startTime":"0","endTime":"0","summary":"CITIC Securities has issued a research report stating that amid the overseas expansion of biosimilars, HENLIUS (02696) is demonstrating significant global value, with a clear second growth curve in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","HK0000306701.USD","HK0000306685.HKD","HK0000320223.HKD","02696","EWH","HK0000320264.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675392232","title":"Shanghai Henlius Biotech (SEHK:2696) Could Be 73% Undervalued On Chairman Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2675392232","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675392232?lang=en_us&edition=fundamental","pubTime":"2026-10-14 08:28","pubTimestamp":1791937723,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech (SEHK:2696) is back in focus after both Chairman Wenjie Zhang and independent director Yihao Zhang resigned on 30 September 2026, and long-time industry executive Dr. Xingli Wang stepped in as the new chair.\nShanghai Henlius Biotech’s share price has slipped over the past quarter, with a 30 day share price return of down 15.24% and a 90 day move of down 15.91%, while the 1 year total shareholder return of down 19.82% sits against a very large 3 year total shareholder...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-could-be-73-undervalued-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-biotech-sehk2696-could-be-73-undervalued-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XBI","HK0000165453.HKD","HK0000320223.HKD","02696","BK1161","BK4588","HK0000306701.USD","DCF","BK4581","HK0000306685.HKD","HK0000320264.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675382931","title":"How Investors Are Reacting To Henlius Shares After A Chairman Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2675382931","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675382931?lang=en_us&edition=fundamental","pubTime":"2026-10-13 07:34","pubTimestamp":1791848060,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech reported that Chairman and non executive director Wenjie Zhang and independent director Yihao Zhang resigned on 30 September 2026 for personal development reasons, with long serving industry executive Dr. Xingli Wang stepping in as chair and taking over key committee leadership roles.\nThe leadership shift concentrates board influence with a senior Fosun Pharma executive, which could shape how Shanghai Henlius Biotech balances capital allocation, R&D priorities, and...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/how-investors-are-reacting-to-henlius-shares-after-a-chairma","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/how-investors-are-reacting-to-henlius-shares-after-a-chairma","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000320264.USD","02696","HK0000306685.HKD","HK0000306701.USD","ISBC","BK4211","BK4581","HK0000320223.HKD","BK1161","XBI","BK4585","HK0000165453.HKD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157935783","title":"Hong Kong Stock Movement: HENLIUS Opens Over 4% Higher as PD-L1/VEGF Bispecific Antibody Initiates Phase 2/3 Clinical Trial for First-Line NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1157935783","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157935783?lang=en_us&edition=fundamental","pubTime":"2026-10-09 09:30","pubTimestamp":1791509417,"startTime":"0","endTime":"0","summary":"According to a report, HENLIUS (02696) opened more than 4% higher. As of press time, the stock rose 4.64% to HK$53.0, with a turnover of HK$47,700.On the news front, on October 8, HENLIUS registered...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02696","HK0000306685.HKD","HK0000320264.USD","VXUS","BK4588","HK0000306701.USD","KCAI","HK0000320223.HKD","BK4585","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672426738","title":"Shanghai Henlius Stock And The Amberstone Licensing Deal Explained","url":"https://stock-news.laohu8.com/highlight/detail?id=2672426738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672426738?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:21","pubTimestamp":1790778087,"startTime":"0","endTime":"0","summary":"Shanghai Henlius Biotech entered a collaboration and license agreement with Amberstone Biosciences, securing exclusive rights to research, develop, manufacture, and commercialize products using Amberstone technology in its territory, in return for a US$4 million upfront fee, up to US$232.16 million in R&D and regulatory milestones, up to US$652 million in sales milestones, and single digit royalty payments.\nThis structure ties Shanghai Henlius Biotech’s future cash commitments directly to...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-stock-and-the-amberstone-licensing-deal-exp","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2696/shanghai-henlius-biotech-shares/news/shanghai-henlius-stock-and-the-amberstone-licensing-deal-exp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4581","02696","XBI","HK0000165453.HKD","HK0000306701.USD","BK4585","BK1161","HK0000320264.USD","HK0000306685.HKD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118344822","title":"HENLIUS Announces Board Leadership Change as Xingli Wang Named Chairman of Fourth Board","url":"https://stock-news.laohu8.com/highlight/detail?id=1118344822","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118344822?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:16","pubTimestamp":1790759786,"startTime":"0","endTime":"0","summary":"HENLIUS (ASX: 02696) has issued an announcement regarding significant changes to its board composition.Due to personal development reasons, Mr. Wenjie Zhang has tendered his resignation as a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","BK1161","HK0000320223.HKD","HK0000306685.HKD","02696","HK0000165453.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671778842","title":"Shanghai Henlius Biotech, - Wenjie Zhang Resigns as Chairman Effective Sept 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671778842","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671778842?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:11","pubTimestamp":1790759484,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696","HK0000320264.USD","HK0000306701.USD","HK0000165453.HKD","HK0000306685.HKD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138554772","title":"Henlius Biotech (02696) Climbs Nearly 6% as Core Pipeline Value Continues to Be Validated; H Drug to Debut U.S. Patient Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1138554772","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138554772?lang=en_us&edition=fundamental","pubTime":"2026-09-30 15:30","pubTimestamp":1790753415,"startTime":"0","endTime":"0","summary":"According to Zhitong Finance APP, Henlius Biotech (HKEX: 02696) rose nearly 6%, up 5.83% as of press time to HK$58.95, with a turnover of HK$41.6221 million.On the news front, the 2026 European...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","VXUS","HK0000165453.HKD","HK0000306701.USD","BK1161","BK4585","HK0000306685.HKD","02696","HK0000320223.HKD","BK4588","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171948968","title":"Henlius Jumps Over 5% Intraday as Two Hansizhuang® Studies in Gastrointestinal Oncology Debut at ASTRO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1171948968","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171948968?lang=en_us&edition=fundamental","pubTime":"2026-09-29 11:50","pubTimestamp":1790653824,"startTime":"0","endTime":"0","summary":"Henlius Biotech (02696) rose more than 5% intraday, and as of press time the stock was up 2.28% at HK$56.05, with turnover of HK$15.3369 million.According to a post on the official WeChat account of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","BK1161","HK0000306685.HKD","HK0000320264.USD","HK0000320223.HKD","HK0000306701.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464543","title":"Amberstone Biosciences and Henlius Enter into Collaboration and License Agreement for Conditionally Activated T-Cell Engagers for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464543?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:33","pubTimestamp":1790246003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0SL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000320264.USD","HK0000320223.HKD","02696","BK1161","HK0000306685.HKD","HK0000306701.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669358107","title":"Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2669358107","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669358107?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:17","pubTimestamp":1790158640,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical   unit Shanghai Henlius Biotech  signed a collaboration and exclusive license deal with Amberstone Biosciences for two T-cell engager products, according to a Wednesday Shanghai bourse filing.Under the deal, Henlius Biotech received exclusive global rights to research, develop, manufacture and commercialize the products for all human uses based on Amberstone's T-MATE technology platform and two designated targets.Henlius Biotech will pay Amberstone up to $236.2 million in upfront, research, development and regulatory milestone payments, plus up to $652 million in sales milestones, it said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000320223.HKD","BK0175","BK0096","BK1515","BK0012","BK1593","BK0188","XBI","BK1161","BK0028","HK0000320264.USD","600196","BK1191","BK0183","BK0060","BK4585","HK0000306701.USD","BK0196","HK0000165453.HKD","BK0187","BK0239","HK0000306685.HKD","02196","BK4581","02696","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197775203","title":"HENLIUS Enters Global Collaboration and Licensing Agreement with Amberstone for Two T-Cell Engager Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=1197775203","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197775203?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:03","pubTimestamp":1790154183,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) has announced that on September 23, 2026, the company entered into a collaboration and licensing agreement with Amberstone Biosciences, Inc. (\"Amberstone\", collectively with the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696","HK0000320264.USD","HK0000165453.HKD","HK0000306701.USD","BK1161","HK0000320223.HKD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669365101","title":"Shanghai Henlius Biotech, - to Pay Amberstone Upfront Payment of $4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2669365101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669365101?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:59","pubTimestamp":1790153966,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F09E:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000320264.USD","HK0000306685.HKD","HK0000165453.HKD","HK0000320223.HKD","BK1161","HK0000306701.USD","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669101854","title":"Shanghai Henlius Biotech, - Enters Collaboration and License Agreement with Amberstone Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2669101854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669101854?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:59","pubTimestamp":1790153966,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F09E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696","HK0000306685.HKD","HK0000320264.USD","HK0000306701.USD","HK0000320223.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669018551","title":"Shanghai Henlius Biotech, - Agreement Covers Worldwide Research and Commercialization of Two T Cell Engager Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2669018551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669018551?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:59","pubTimestamp":1790153966,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F09E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02696","HK0000306685.HKD","HK0000320264.USD","HK0000306701.USD","HK0000320223.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117397705","title":"HENLIUS Surges Over 8% on Pakistan Approval and Inclusion in National Essential Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1117397705","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117397705?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:58","pubTimestamp":1789955899,"startTime":"0","endTime":"0","summary":"HENLIUS (02696) saw its shares jump more than 8% in morning trading, with the stock last changing hands at HK$64.80, representing an 8.56% gain, and turnover reaching HK$20.10 million.On the news...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","BK4588","HK0000320223.HKD","BK4585","KCAI","02696","BK1161","VXUS","HK0000320264.USD","HK0000306701.USD","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668948860","title":"Shanghai FTZ Fund-Backed Henlius Enters Stock Connect List in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2668948860","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668948860?lang=en_us&edition=fundamental","pubTime":"2026-09-18 14:26","pubTimestamp":1789712768,"startTime":"0","endTime":"0","summary":"Shanghai FTZ fund-backed Henlius enters Stock Connect list in Hong KongShanghai Free Trade Zone Equity Investment Fund Management flagged multiple portfolio milestones across awards, policy designatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL1Ln00Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","HK0000320223.HKD","HK0000306685.HKD","BK1161","02696","HK0000165453.HKD","HK0000306701.USD","00656","BK1230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134723592","title":"Quarterly Rebalancing Alert: Huabao's HK Stock Connect Innovative Drug ETF (520880) Welcomes Five New Constituents While Dropping Three","url":"https://stock-news.laohu8.com/highlight/detail?id=1134723592","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134723592?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471241,"startTime":"0","endTime":"0","summary":"The quarterly index rebalancing for HK Stock Connect innovative drug stocks is officially in effect as of September 14th, prompting a synchronized portfolio refresh for the Huabao Hang Seng HK Stock...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159316","520880","02696","BK1161","HK0000165453.HKD","HK0000306701.USD","HK0000320223.HKD","HK0000306685.HKD","HK0000320264.USD","FLHK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":-0.2168},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.4028},{"period":"1year","weight":-0.3069},{"period":"ytd","weight":-0.1337}],"compareEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":-0.0858},{"period":"3month","weight":-0.0813},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.1104},{"period":"ytd","weight":-0.1052}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Shanghai Henlius Biotech Inc is a China-based company principally engaged in biopharmaceutical research and development, biopharmaceutical services and biopharmaceutical production and sales. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044394},{"month":2,"riseRate":0.714286,"avgChangeRate":0.117695},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.008815},{"month":4,"riseRate":0.857143,"avgChangeRate":0.12138},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.033714},{"month":6,"riseRate":0.571429,"avgChangeRate":0.085211},{"month":7,"riseRate":0.428571,"avgChangeRate":0.040127},{"month":8,"riseRate":0.571429,"avgChangeRate":0.005816},{"month":9,"riseRate":0,"avgChangeRate":-0.125139},{"month":10,"riseRate":0.25,"avgChangeRate":-0.042007},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058675},{"month":12,"riseRate":0.714286,"avgChangeRate":-0.023816}],"exchange":"SEHK","name":"HENLIUS","nameEN":"HENLIUS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HENLIUS,02696,HENLIUS股票,HENLIUS股票老虎,HENLIUS股票老虎国际,HENLIUS行情,HENLIUS股票行情,HENLIUS股价,HENLIUS股市,HENLIUS股票价格,HENLIUS股票交易,HENLIUS股票购买,HENLIUS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HENLIUS(02696),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HENLIUS(02696) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}